{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:29:36Z","timestamp":1786501776712,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["24K02895"],"award-info":[{"award-number":["24K02895"]}]},{"name":"JSPS KAKENHI","award":["JP24H00624"],"award-info":[{"award-number":["JP24H00624"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["JP24dk0207074h000"],"award-info":[{"award-number":["JP24dk0207074h000"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K21773"],"award-info":[{"award-number":["25K21773"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Promotion of Fundamental Studies in dementia of the Tokyo Metropolitan Government"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02336-5","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:45:04Z","timestamp":1780904704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing heme synthesis attenuates pathological \u03b1-synuclein propagation in vivo"],"prefix":"10.1186","volume":"14","author":[{"given":"Masami","family":"Masuda-Suzukake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2336_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/life15081168","author":"Y Abe","year":"2025","unstructured":"Abe Y, Hamasaki T, Natsume J, Mogami Y, Murayama K, Shiraishi H, Abe Y, Kumada S, Tanaka R, Ihara K et al (2025) Efficacy and safety of 5-aminolevulinic acid hydrochloride combined with sodium ferrous citrate in pediatric patients with leigh syndrome and central nervous system disorders: an initial exploratory trial with a double-blind placebo-controlled period, followed by an open-label period and a subsequent long-term administration study. Life (Basel). https:\/\/doi.org\/10.3390\/life15081168","journal-title":"Life (Basel)."},{"key":"2336_CR2","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.1073\/pnas.192585799","volume":"99","author":"H Atamna","year":"2002","unstructured":"Atamna H, Killilea DW, Killilea AN, Ames BN (2002) Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci U S A 99:14807\u201314812. https:\/\/doi.org\/10.1073\/pnas.192585799","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2336_CR3","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"2336_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15965","author":"A Belot","year":"2024","unstructured":"Belot A, Puy H, Hamza I, Bonkovsky HL (2024) Update on heme biosynthesis, tissue-specific regulation, heme transport, relation to iron metabolism and cellular energy. Liver Int. https:\/\/doi.org\/10.1111\/liv.15965","journal-title":"Liver Int"},{"key":"2336_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2336_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2020.06.008","volume":"490","author":"A Casas","year":"2020","unstructured":"Casas A (2020) Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. Cancer Lett 490:165\u2013173. https:\/\/doi.org\/10.1016\/j.canlet.2020.06.008","journal-title":"Cancer Lett"},{"key":"2336_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3389\/fnins.2018.00712","volume":"12","author":"D Chiabrando","year":"2018","unstructured":"Chiabrando D, Fiorito V, Petrillo S, Tolosano E (2018) Unraveling the role of Heme in neurodegeneration. Front Neurosci 12:712. https:\/\/doi.org\/10.3389\/fnins.2018.00712","journal-title":"Front Neurosci"},{"key":"2336_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115320","volume":"164","author":"Z Ding","year":"2025","unstructured":"Ding Z, Ma K, Kamiya A, Ito H, Takahashi K, Nakajima M, Wang C, Fujino M, Li XK (2025) 5-aminolaevulinic acid combined with sodium ferrous citrate ameliorated collagen-induced arthritis via anti-inflammatory effects and fibroblast-like synoviocytes-driven B cell immunomodulation. Int Immunopharmacol 164:115320. https:\/\/doi.org\/10.1016\/j.intimp.2025.115320","journal-title":"Int Immunopharmacol"},{"key":"2336_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11020164","author":"S Hirose","year":"2022","unstructured":"Hirose S, Isoda N, Huynh LT, Kim T, Yoshimoto K, Tanaka T, Inui K, Hiono T, Sakoda Y (2022) Antiviral effects of 5-aminolevulinic acid phosphate against classical swine fever virus: in vitro and in vivo evaluation. Pathogens. https:\/\/doi.org\/10.3390\/pathogens11020164","journal-title":"Pathogens"},{"key":"2336_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12952","volume":"31","author":"I Kawakami","year":"2021","unstructured":"Kawakami I, Motoda A, Hashimoto M, Shimozawa A, Masuda-Suzukake M, Ohtani R, Takase M, Kumashiro M, Samejima K, Hasegawa M (2021) Progression of phosphorylated alpha-synuclein in Macaca fuscata. Brain Pathol 31:e12952. https:\/\/doi.org\/10.1111\/bpa.12952","journal-title":"Brain Pathol"},{"key":"2336_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/oby.23705","volume":"31","author":"N Kitamura","year":"2023","unstructured":"Kitamura N, Zhang S, Morel JD, Nagano U, Taworntawat T, Hosoda S, Nakamura A, Ogawa Y, Benegiamo G, Auwerx J et al (2023) Sodium ferrous citrate and 5-aminolevulinic acid improve type 2 diabetes by maintaining muscle and mitochondrial health. Obesity (Silver Spring) 31:1038\u20131049. https:\/\/doi.org\/10.1002\/oby.23705","journal-title":"Obesity (Silver Spring)"},{"key":"2336_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/25785826.2024.2445399","volume":"48","author":"T Koga","year":"2025","unstructured":"Koga T, Kita K, Okumura J, Yoshiura KI, Kawakami A (2025) A novel frameshift mutation in ADCK1 identified in a case of chronic fatigue syndrome successfully treated with oral 5-ALA\/SFC. Immunol Med 48:251\u2013255. https:\/\/doi.org\/10.1080\/25785826.2024.2445399","journal-title":"Immunol Med"},{"key":"2336_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM (2012) Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338:949\u2013953. https:\/\/doi.org\/10.1126\/science.1227157","journal-title":"Science"},{"key":"2336_CR14","first-page":"95","volume":"8","author":"SM Massa","year":"1996","unstructured":"Massa SM, Swanson RA, Sharp FR (1996) The stress gene response in brain. Cerebrovasc Brain Metab Rev 8:95\u2013158","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"2336_CR15","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.febslet.2006.02.032","volume":"580","author":"M Masuda","year":"2006","unstructured":"Masuda M, Dohmae N, Nonaka T, Oikawa T, Hisanaga S, Goedert M, Hasegawa M (2006) Cysteine misincorporation in bacterially expressed human alpha-synuclein. FEBS Lett 580:1775\u20131779. https:\/\/doi.org\/10.1016\/j.febslet.2006.02.032","journal-title":"FEBS Lett"},{"key":"2336_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.febslet.2009.01.037","volume":"583","author":"M Masuda","year":"2009","unstructured":"Masuda M, Hasegawa M, Nonaka T, Oikawa T, Yonetani M, Yamaguchi Y, Kato K, Hisanaga S, Goedert M (2009) Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. FEBS Lett 583:787\u2013791. https:\/\/doi.org\/10.1016\/j.febslet.2009.01.037","journal-title":"FEBS Lett"},{"key":"2336_CR17","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1021\/bi0600749","volume":"45","author":"M Masuda","year":"2006","unstructured":"Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M (2006) Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry 45:6085\u20136094. https:\/\/doi.org\/10.1021\/bi0600749","journal-title":"Biochemistry"},{"key":"2336_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H, Hasegawa M (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88. https:\/\/doi.org\/10.1186\/s40478-014-0088-8","journal-title":"Acta Neuropathol Commun"},{"key":"2336_CR19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136:1128\u20131138. https:\/\/doi.org\/10.1093\/brain\/awt037","journal-title":"Brain"},{"key":"2336_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/acs.bioconjchem.1c00123","volume":"32","author":"DA Mendonca","year":"2021","unstructured":"Mendonca DA, Bakker M, Cruz-Oliveira C, Neves V, Jimenez MA, Defaus S, Cavaco M, Veiga AS, Cadima-Couto I, Castanho M et al (2021) Penetrating the blood-brain barrier with new peptide-porphyrin conjugates having anti-HIV activity. Bioconjug Chem 32:1067\u20131077. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00123","journal-title":"Bioconjug Chem"},{"key":"2336_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281399","volume":"18","author":"E Nara","year":"2023","unstructured":"Nara E, Lai HW, Imazato H, Ishizuka M, Nakajima M, Ogura SI (2023) Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro. PLoS ONE 18:e0281399. https:\/\/doi.org\/10.1371\/journal.pone.0281399","journal-title":"PLoS ONE"},{"key":"2336_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41182-022-00422-7","volume":"50","author":"MM Ngwe Tun","year":"2022","unstructured":"Ngwe Tun MM, Sakura T, Sakurai Y, Kurosaki Y, Inaoka DK, Shioda N, Smith C, Yasuda J, Morita K, Kita K (2022) 5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro. Trop Med Health 50:30. https:\/\/doi.org\/10.1186\/s41182-022-00422-7","journal-title":"Trop Med Health"},{"key":"2336_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/2211-5463.13338","volume":"12","author":"N Nozawa","year":"2022","unstructured":"Nozawa N, Noguchi M, Shinno K, Tajima M, Aizawa S, Saito T, Asada A, Ishii T, Ishizuka M, Iijima KM et al (2022) 5-Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila. FEBS Open Bio 12:295\u2013305. https:\/\/doi.org\/10.1002\/2211-5463.13338","journal-title":"FEBS Open Bio"},{"key":"2336_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-66","volume":"4","author":"S Ogura","year":"2011","unstructured":"Ogura S, Maruyama K, Hagiya Y, Sugiyama Y, Tsuchiya K, Takahashi K, Abe F, Tabata K, Okura I, Nakajima M et al (2011) The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. BMC Res Notes 4:66. https:\/\/doi.org\/10.1186\/1756-0500-4-66","journal-title":"BMC Res Notes"},{"key":"2336_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1006\/exnr.1997.6752","volume":"150","author":"HM Schipper","year":"1998","unstructured":"Schipper HM, Liberman A, Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson\u2019s disease. Exp Neurol 150:60\u201368. https:\/\/doi.org\/10.1006\/exnr.1997.6752","journal-title":"Exp Neurol"},{"key":"2336_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga SI, Hasegawa M (2017) Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun 5:12. https:\/\/doi.org\/10.1186\/s40478-017-0413-0","journal-title":"Acta Neuropathol Commun"},{"key":"2336_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41591-018-0018-6","volume":"24","author":"N Shioda","year":"2018","unstructured":"Shioda N, Yabuki Y, Yamaguchi K, Onozato M, Li Y, Kurosawa K, Tanabe H, Okamoto N, Era T, Sugiyama H et al (2018) Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome. Nat Med 24:802\u2013813. https:\/\/doi.org\/10.1038\/s41591-018-0018-6","journal-title":"Nat Med"},{"key":"2336_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fnins.2019.00595","volume":"13","author":"A Shimozawa","year":"2019","unstructured":"Shimozawa A, Fujita Y, Kondo H, Takimoto Y, Terada M, Sanagi M, Hisanaga SI, Hasegawa M (2019) Effect of L-DOPA\/benserazide on propagation of pathological a-synuclein. Front Neurosci 13:595. https:\/\/doi.org\/10.3389\/fnins.2019.00595","journal-title":"Front Neurosci"},{"key":"2336_CR29","first-page":"42","volume":"145","author":"MA Smith","year":"1994","unstructured":"Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s disease. Am J Pathol 145:42\u201347","journal-title":"Am J Pathol"},{"key":"2336_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1471-4159.2009.06165.x","volume":"110","author":"W Song","year":"2009","unstructured":"Song W, Patel A, Qureshi HY, Han D, Schipper HM, Paudel HK (2009) The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. J Neurochem 110:719\u2013733. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06165.x","journal-title":"J Neurochem"},{"key":"2336_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 251:205\u2013208","journal-title":"Neurosci Lett"},{"key":"2336_CR32","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"2336_CR33","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2025.01106","author":"R Sumiyoshi","year":"2025","unstructured":"Sumiyoshi R, Koga T, Kamisawa O, Morimoto S, Hosogaya N, Yamamoto H, Hori M, Inaba Y, Hattori Y, Hikake T et al (2025) A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride\/sodium ferrous citrate (5-ALA-HCl\/SFC) for patients with adult-onset Still\u2019s disease (AOSD) refractory to glucocorticoids. Drug Discov Ther. https:\/\/doi.org\/10.5582\/ddt.2025.01106","journal-title":"Drug Discov Ther"},{"key":"2336_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.647189","volume":"8","author":"T Takano","year":"2021","unstructured":"Takano T, Satoh K, Doki T (2021) Possible antiviral activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) infection. Front Vet Sci 8:647189. https:\/\/doi.org\/10.3389\/fvets.2021.647189","journal-title":"Front Vet Sci"},{"key":"2336_CR35","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M408714200","volume":"280","author":"S Taniguchi","year":"2005","unstructured":"Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614\u20137623. https:\/\/doi.org\/10.1074\/jbc.M408714200","journal-title":"J Biol Chem"},{"key":"2336_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040738","author":"T Todorovski","year":"2022","unstructured":"Todorovski T, Mendonca DA, Fernandes-Siqueira LO, Cruz-Oliveira C, Guida G, Valle J, Cavaco M, Limas FIV, Neves V, Cadima-Couto I et al (2022) Targeting Zika virus with new brain- and placenta-crossing peptide-porphyrin conjugates. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14040738","journal-title":"Pharmaceutics"},{"key":"2336_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s1011-1344(98)00102-x","volume":"44","author":"J van den Boogert","year":"1998","unstructured":"van den Boogert J, van Hillegersberg R, de Rooij FW, de Bruin RW, Edixhoven-Bosdijk A, Houtsmuller AB, Siersema PD, Wilson JH, Tilanus HW (1998) 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B Biol 44:29\u201338. https:\/\/doi.org\/10.1016\/s1011-1344(98)00102-x","journal-title":"J Photochem Photobiol B Biol"},{"key":"2336_CR38","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1074\/jbc.M807482200","volume":"284","author":"M Yonetani","year":"2009","unstructured":"Yonetani M, Nonaka T, Masuda M, Inukai Y, Oikawa T, Hisanaga S, Hasegawa M (2009) Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant. J Biol Chem 284:7940\u20137950. https:\/\/doi.org\/10.1074\/jbc.M807482200","journal-title":"J Biol Chem"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02336-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02336-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02336-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:16:30Z","timestamp":1786500990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02336-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02336-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8913900\/v1","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"165"}}